Qualitative and semiquantitative parameters of 18F-FDG-PET/CT as predictors of malignancy in patients with solitary pulmonary nodule

Simple Summary This study aims to evaluate the reliability of qualitative and semiquantitative parameters of F-18-FDG PET-CT, and eventually a correlation between them, in predicting the risk of malignancy in patients with solitary pulmonary nodule (SPN) before the diagnosis of lung cancer. Qualitative and semiquantitative parameters can be considered reliable tools in patients with SPN, since cut-offs for SUVmax, SUVmean, TLG and MTV showed good sensitivity and specificity in predicting malignancy. This study aims to evaluate the reliability of qualitative and semiquantitative parameters of F-18-FDG PET-CT, and eventually a correlation between them, in predicting the risk of malignancy in patients with solitary pulmonary nodules (SPNs) before the diagnosis of lung cancer. A total of 146 patients were retrospectively studied according to their pre-test probability of malignancy (all patients were intermediate risk), based on radiological features and risk factors, and qualitative and semiquantitative parameters, such as SUVmax, SUVmean, TLG, and MTV, which were obtained from the FDG PET-CT scan of such patients before diagnosis. It has been observed that visual analysis correlates well with the risk of malignancy in patients with SPN; indeed, only 20% of SPNs in which FDG uptake was low or absent were found to be malignant at the cytopathological examination, while 45.45% of SPNs in which FDG uptake was moderate and 90.24% in which FDG uptake was intense were found to be malignant. The same trend was observed evaluating semiquantitative parameters, since increasing values of SUVmax, SUVmean, TLG, and MTV were observed in patients whose cytopathological examination of SPN showed the presence of lung cancer. In particular, in patients whose SPN was neoplastic, we observed a median (MAD) SUVmax of 7.89 (+/- 2.24), median (MAD) SUVmean of 3.76 (+/- 2.59), median (MAD) TLG of 16.36 (+/- 15.87), and a median (MAD) MTV of 3.39 (+/- 2.86). In contrast, in patients whose SPN was non-neoplastic, the SUVmax was 2.24 (+/- 1.73), SUVmean 1.67 (+/- 1.15), TLG 1.63 (+/- 2.33), and MTV 1.20 (+/- 1.20). Optimal cut-offs were drawn for semiquantitative parameters considered predictors of malignancy. Nodule size correlated significantly with FDG uptake intensity and with SUVmax. Finally, age and nodule size proved significant predictors of malignancy. In conclusion, considering the pre-test probability of malignancy, qualitative and semiquantitative parameters can be considered reliable tools in patients with SPN, since cut-offs for SUVmax, SUVmean, TLG, and MTV showed good sensitivity and specificity in predicting malignancy.